Telemetry Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Telemetry Investments’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$484K	Buy	32,250 +12,250	+61%	+$112K	1.13%	32
2022 Q3	$236K	Sell	20,000 -3,000	-13%	-$40.6K	0.39%	80
2022 Q2	$260K	Buy	23,000 +9,500	+70%	+$191K	0.4%	89
2022 Q1	$404K	Sell	13,500 -5,500	-29%	-$149K	0.65%	59
2021 Q4	$504K	Buy	19,000 +6,750	+55%	+$204K	0.66%	52
2021 Q3	$445K	Buy	12,250 +4,250	+53%	+$167K	0.61%	56
2021 Q2	$347K	Sell	8,000 -1,000	-11%	-$37.8K	0.48%	69
2021 Q1	$308K	Sell	9,000 -1,601	-15%	-$63.4K	0.35%	93
2020 Q4	$371K	Sell	10,601 -21,899	-67%	-$634K	0.68%	59
2020 Q3	$780K	Buy	32,500 +9,950	+44%	+$244K	1.84%	25
2020 Q2	$413K	Hold	22,550	–	–	1.25%	38
2020 Q1	$352K	Hold	22,550	–	–	1.38%	33
2019 Q4	$483K	Sell	22,550 -200	-0.9%	-$4.12K	1.69%	21
2019 Q3	$425K	Sell	22,750 -650	-3%	-$13.4K	1.32%	22
2019 Q2	$611K	Sell	23,400 -6,600	-22%	-$149K	1.22%	36
2019 Q1	$771K	Buy	30,000 +4,000	+15%	+$91.4K	1.55%	36
2018 Q4	$598K	Buy	26,000 +13,900	+115%	+$392K	0.8%	65
2018 Q3	$388K	Sell	12,100 -5,900	-33%	-$177K	0.58%	71
2018 Q2	$509K	Buy	18,000 +5,500	+44%	+$196K	0.61%	58
2018 Q1	$442K	Sell	12,500 -11,490	-48%	-$460K	0.48%	80
2017 Q4	$931K	Buy	23,990 +3,990	+20%	+$152K	1.18%	51
2017 Q3	$508K	Sell	20,000 -2,000	-9%	-$48.6K	0.52%	72
2017 Q2	$601K	Buy	22,000 +5,000	+29%	+$137K	0.67%	63
2017 Q1	$563K	Buy	17,000 +1,831	+12%	+$46.7K	0.62%	59
2016 Q4	$361K	Buy	15,169 +6,269	+70%	+$180K	0.48%	63
2016 Q3	$327K	Buy	8,900 +400	+5%	+$11.5K	0.37%	63
2016 Q2	$190K	Sell	8,500 -11,500	-58%	-$286K	0.21%	97
2016 Q1	$416K	Sell	20,000 -5,000	-20%	-$123K	0.37%	64
2015 Q4	$758K	Hold	25,000	–	–	0.48%	60
2015 Q3	$618K	Hold	25,000	–	–	0.34%	79
2015 Q2	$802K	Buy	25,000 +5,000	+25%	+$191K	0.51%	60
2015 Q1	$714K	Sell	20,000 -10,000	-33%	-$274K	0.53%	51
2014 Q4	$681K	Buy	+30,000	New	+$607K	0.49%	63